Neuroprotective role of PKR in a model of neurodegeneration due to mild impairment of oxidative metabolism by François Mouton-Liger et al.
POSTER PRESENTATION Open Access
Neuroprotective role of PKR in a model of
neurodegeneration due to mild impairment
of oxidative metabolism
François Mouton-Liger1,2*, Anne-Sophie Rebillat1, Sarah Gourmaud1, Audrey Leguen1, Claire Paquet1,2,
Laurent Pradier3, Thomas Rooney3, Jacques Hugon1,2
From Molecular Neurodegeneration: Basic biology and disease pathways
Cannes, France. 10-12 September 2013
Background
Abnormalities in oxidative metabolism, inflammation,
and selective neuronal death are described features of
Alzheimer’s disease (AD) pathology. Brain thiamine-
dependent enzymes play an important role in energy
metabolism and display reduced activity in AD. Thiamine
(vitamin B1) deficiency (TD) induces regionally selective
neuronal death in animal and human brains. TD-induced
neuronal loss is associated with a mild and chronic
impairment of oxidative metabolism as well as inflamma-
tory responses with cytokine production. These features
make the TD model amenable to investigate the cellular
mechanisms of neurodegeneration. PKR (double
stranded-RNA dependent protein kinase) is activated by
Aß1-42, and by various cellular stresses including oxida-
tive stress. Once activated, PKR acts as a pro-apoptotic
kinase and negatively controls the initial step of protein
translation by the elF2a phosphorylation, leading to an
increase of BACE1 translation. In addition, it has been
demonstrated that TD promotes PKR activation.
Learning objective
The goal of this study was to use the TD model in mice
to assess in vivo the involvement of PKR in the neuronal
death, inflammation and in the neuropathological
mechanisms of AD. All results of this TD model are
compared with those obtained in controls (saline
injected).
Methods
C57BL/6J mice, housed in a controlled environment,
have been fed either a control diet or a thiamine deficient
diet ad libitum. TD animals also received a daily intraperi-
toneal injection of a thiamine antagonist, pyrithiamine
hydrobromide for 10 days while control animals will be
injected with saline.
Results
Our results showed that the PKR-elF2a pathway,
BACE1 levels and Ab production are increased in the
thalamus and cerebellum of the TD model. These findings
are associated with microglial activation and neuronal
death. Performance on the rotarod task also declines in
the animal TD model in a highly reproducible manner.
Conclusion
Our findings suggest a role in vivo of the kinase PKR in
neuronal degeneration linked to oxidative metabolism
impairment.
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